home / stock / glsi / glsi news


GLSI News and Press, Greenwich LifeSciences Inc. From 04/05/21

Stock Information

Company Name: Greenwich LifeSciences Inc.
Stock Symbol: GLSI
Market: NASDAQ
Website: greenwichlifesciences.com

Menu

GLSI GLSI Quote GLSI Short GLSI News GLSI Articles GLSI Message Board
Get GLSI Alerts

News, Short Squeeze, Breakout and More Instantly...

GLSI - Chembio Diagnostics, Nano-X Imaging leads healthcare gainers; Molecular Templates, ACADIA Pharmaceuticals among major losers

Gainers: Chembio Diagnostics CEMI +60%, Nano-X Imaging NNOX +25%, NanoVibronix (NAOV) +16%, Vivos Therapeutics (VVOS) +15%, Greenwich LifeSciences (GLSI) +14%.Losers: Molecular Templates (MTEM) -26%, ACADIA Pharmaceuticals ACAD -17%,...

GLSI - Greenwich LifeSciences Is Both a Sound Investment and a Feel-Good Buy

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Greenwich LifeSciences  (NASDAQ: GLSI ) is on the front lines of the ongoing battle against breast cancer. After learning about this Texas-based biotech business, you might decide to take a long-term position...

GLSI - Greenwich LifeSciences CEO to Participate on Cancer Panel and to Present at Benzinga Biotech Conference

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced that CEO Sneh...

GLSI - Greenwich LifeSciences Updates 2021 Timeline & Announces Two Upcoming Presentations at the American Association for Cancer Research Annual Meeting

Presenting final 5 year immune response data from the Phase IIb clinical trial for recurring breast cancer Planning completion of GP2 manufacturing in 2nd/3rd quarter of 2021 Presenting updated design for Phase III clinical trial that is planned to commence in 3rd/4th quarter ...

GLSI - Greenwich LifeSciences CEO to be Interviewed Live on Benzinga's Power Hour

Interview will air on Thursday, March 11, 2021 at 12:30 pm EST Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patien...

GLSI - RIOT, SFIX, WPG and ACAD among midday movers

Gainers: Exela Technologies (XELA) +163%.Oragenics (OGEN) +47%.ReneSola (SOL) +42%.Auris Medical (EARS) +39%.The9 (NCTY) +37%.Canaan (CAN) +36%.AnPac Bio-Medical Science (ANPC) +36%.Riot Blockchain (RIOT) +35%.Washington Prime (WPG) +30%.Socket Mobile (SCKT) +23%.Losers: G...

GLSI - GME, RIOT, NVTA and MARA among premarket gainers

AnPac Bio-Medical Science (ANPC) +75% after update on cancer detection system CDAPS.Second Sight Medical Products (EYES) +67%.GT Biopharma (GTBP) +45%.Auris Medical Holding Ltd. (EARS) +24%.Taoping Inc. (TAOP) +10% on launching Blockchain Business Division.AirNet Technology (ANTE) +...

GLSI - Why Greenwich LifeSciences Stock Skyrocketed Today

Shares of Greenwich LifeSciences (NASDAQ: GLSI) were skyrocketing 48.8% higher as of 3:19 p.m. EST on Monday. The huge jump came after the company announced the hiring of Jaye Thompson as vice president of clinical and regulatory affairs. It's unusual for the addition of a new v...

GLSI - Trading in Greenwich LifeSciences briefly halted following huge upswing

Trading in microcap Greenwich LifeSciences, Inc. (GLSI) was briefly halted this afternoon following a major upswing in its share price that started around 12:45p ET and peaked at around 1:30p.Trading resumed just after 2p.At its peak at 1:27p today, Greenwich shares reached $52.27, 127% highe...

GLSI - GME, BILI, JAGX and SOS among midday movers

Gainers: Second Sight Medical Products (EYES) +94%.OpGen (OPGN) +71%.Anchiano Therapeutics (ANCN) +66%.GameStop (GME) +44%.Jaguar Health (JAGX) +35%.Moxian (MOXC) +30%.Koss (KOSS) +30%.Idera Pharmaceuticals (IDRA) +28%.BSQUARE (BSQR) +25%.Greenwich LifeSciences (GLSI) +23%.Losers:&#...

Previous 10 Next 10